Combined Modality Treatment for Stages III and IV Hodgkin's Disease.
Research committees
Publication Information Expand/Collapse
2008
The Southwest Oncology Group: progress in cancer research [PMID18929152]
1998
Treatment of grey zone lymphomas
1996
Report of workshop 5: Early high-dose chemotherapy.
1994
Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease: A Southwest Oncology Group study
1992
Radiation consolidation following MOP-BAP for stages III & IV Hodgkin's disease: A randomized Southwest Oncology Group study
Role of additional radiotherapy in advanced stages of Hodgkin's disease.
1991
Radiation consolidation following MOP-BAP for stages III & IV Hodgkin's disease. A randomized Southwest Oncology Group study.
1990
Comparison of lymphangiography and CT scanning in evaluating abdominal disease in stages III and IV Hodgkin's disease: A Southwest Oncology Group study.
1989
Efficacy of low dose involved field (LDIF) XRT in producing and maintaining CR following PR induction with MOP-BAP chemotherapy in hodgkin's disease, results of Southwest Oncology Group study 7808
1984
Response rates as a function of age in Hodgkin's disease: A SWOG study
Lack of correlation of Ann Arbor clinical parameters and biopsy determination of liver involvement in stage III and IV Hodgkin's disease: A Southwest Oncology Group (SWOG) study
1983
Correlation of clinical and biopsy determination of liver involvement in Stage III and IV Hodgkin's disease: A Southwest Oncology Group (SWOG) study
1982
Chemotherapy and involved field radiotherapy for Stage III-IV Hodgkin's disease
1981
A protocol for combined modality treatment for Stage III and IV Hodgkin's disease: A Southwest Oncology Group study